MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202537065461 A) filed by Daewoong Pharmaceutical Co. Ltd., Gyeonggi, Republic of Korea, on July 9, for 'pharmaceutical composition comprising enavogliflozin and metformin.'
Inventor(s) include Park, Minhyung; Hwang, On; Ha, Songyi; Kim, Gyoungwon; Kim, Hoe Sung; Cho, Sangeun; and Kim, Gwan Young.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a pharmaceutical composition comprising enavogliflozin and metformin. The pharmaceutical composition, according to the present invention, makes it possible to implement an ...